Anika Therapeutics | ANIK - Marktkapitalisierung

Aktienkurs
15.12
Täglich Wechseln
0.17 1.14%
Monatlich
1.34%
Jährlich
4.35%
Q2 Prognose
14.54




Marktkapitalisierung Veränderung Datum
Abbott USD 178.41B 39.46B 2026-03
Agenus USD 107M 16M 2025-12
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 37.12B 6.68B 2025-12
Integra LifeSciences USD 1.03B 301M 2026-05
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 956M 821M 2026-05
MacroGenics USD 102M 4M 2025-12
Merit Medical Systems USD 4.11B 1.11B 2026-03
Sanofi EUR 100.27B 605.48M 2026-03
Smith & Nephew USD 3.62B 9.7B 2026-05
Stryker USD 125.85B 8.57B 2026-03
Veracyte USD 2.59B 16M 2026-05
Xencor USD 1.09B 256M 2025-12
Zimmer Biomet Holdings USD 17.5B 321M 2026-03